![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV PATIENTS TODAY AND 10 YEARS AGO: DO THEY HAVE THE SAME NEEDS?
RESULTS FROM CROSS SECTIONAL ANALYSIS OF ANRS CO3 AQUITAINE COHORT
|
|
|
from Jules: renal related treatment increased 7 fold - chronic kidney disease increased from 2% to 14%......blood pressure medication increased 4 fold....lipid lowering medication doubled.....see table - all comorbidities prevalence increased quite a lot
![HIV1](../images/110516/110516-4/HIV1.gif)
Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
F Bonnet1,3,4, F Le Marec3, O Leleux3, C Cazanave2,3, E Lazaro1,3, P Duffau1,3,
MA Vandenhende1,3,4, P Mercie1,3,4, D Neau2,3, F Dabis3,4
1Services de Medecine Interne et Maladies Infectieuses, CHU de Bordeaux; 2Service des Maladies Infectieuses et Tropicales, CHU de Bordeaux; 3COREVIH AQUITAINE, CHU de Bordeaux; 4INSERM U893, ISPED, Universite de Bordeaux
![HIV2](../images/110516/110516-4/HIV2.gif)
![HIV3](../images/110516/110516-4/HIV3.gif)
References
[1] Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17-25
[2] Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med 2012;13(8):453-68
[3] Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53(11):1130-9.
[4] Orlando G, Meraviglia P, Cordier L, et al. Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. HIV Med. 2006 Nov;7(8):549-57
![HIV4](../images/110516/110516-4/HIV4.gif)
![HIV5](../images/110516/110516-4/HIV5.gif)
![HIV6](../images/110516/110516-4/HIV6.gif)
![HIV7](../images/110516/110516-4/HIV7.gif)
![HIV8](../images/110516/110516-4/HIV8.gif)
![HIV9](../images/110516/110516-4/HIV9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|